Onderneming ULURU Inc. Other OTC
Aandelen
ULUR
US90403T3086
Farmaceutische producten
Vakgebied
Verkoop per activiteit
USD in miljoen | 2016 | Gewicht | 2017 | Gewicht | Delta |
---|---|---|---|---|---|
Product
99,2
%
| 0 | 17,8 % | 1 | 99,2 % | +805,43% |
License
0,8
%
| 0 | 82,2 % | 0 | 0,8 % | -98,42% |
Verkoop per regio
USD in miljoen | 2016 | Gewicht | 2017 | Gewicht | Delta |
---|---|---|---|---|---|
International
98,4
%
| 0 | 95,4 % | 1 | 98,4 % | +67,21% |
United States
1,6
%
| 0 | 4,6 % | 0 | 1,6 % | -45,26% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vaidehi Shah
CEO | Chief Executive Officer | 47 | 27-02-17 |
Oksana Tiedt
CTO | Chief Tech/Sci/R&D Officer | 48 | 31-03-17 |
Anish Shah
BRD | Director/Board Member | - | 31-03-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Oksana Tiedt
CTO | Chief Tech/Sci/R&D Officer | 48 | 31-03-17 |
Director/Board Member | 57 | 20-07-15 | |
Vaidehi Shah
CEO | Chief Executive Officer | 47 | 27-02-17 |
Anish Shah
BRD | Director/Board Member | - | 31-03-17 |
Arindam Bose
BRD | Director/Board Member | 45 | - |
Robert Mandell
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 20 134 943 | 20 134 943 ( 100,00 %) | 0 | 100,00 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,73% | 739 mld. | |
+32,83% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+15,00% | 240 mld. | |
-5,52% | 206 mld. | |
+6,17% | 164 mld. | |
-0,45% | 162 mld. |